Verastem Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and ...
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, ...
Dyne Therapeutics Announces Appointment of Erick J. Lucera as Chief Financial Officer
Erick J. Lucera Erick J. Lucera, Chief Financial Officer (CFO) of Dyne Therapeutics - Proven financial leader brings decades ...